Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions.
- DOI
- 10.1007/s40121-022-00605-z
- Published
- 2022 Apr
- Container
- Infectious diseases and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40121-022-00605-z,
title = {Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions.},
author = {Balevic SJ and Raja SM and Randell R and Deye GA and Conrad T and Nakamura A and Peyton DH and Shotwell S and Liebman K and Cohen-Wolkowiez M and Guptill JT},
year = {2022},
journal = {Infectious diseases and therapy},
doi = {10.1007/s40121-022-00605-z},
url = {https://doi.org/10.1007/s40121-022-00605-z}
}RIS
TY - JOUR TI - Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions. AU - Balevic SJ AU - Raja SM AU - Randell R AU - Deye GA AU - Conrad T AU - Nakamura A AU - Peyton DH AU - Shotwell S AU - Liebman K AU - Cohen-Wolkowiez M AU - Guptill JT PY - 2022 JO - Infectious diseases and therapy DO - 10.1007/s40121-022-00605-z UR - https://doi.org/10.1007/s40121-022-00605-z ER -
APA
SJ, B., SM, R., R, R., GA, D., T, C., A, N., DH, P., S, S., K, L., M, C., & JT, G. (2022). Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions.. Infectious diseases and therapy. https://doi.org/10.1007/s40121-022-00605-z
Source records
- pubmed · retrieved 2026-09-27T00:45:01.209Z